STOCK TITAN

Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Perrigo Company plc (PRGO) is set to release its fourth quarter and fiscal year 2023 financial results on February 27th, 2024. The earnings conference call will be accessible via webcast or phone, with a replay available until March 5, 2024.
Positive
  • None.
Negative
  • None.

DUBLIN, Feb. 13, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its fourth quarter and fiscal year 2023 financial results on Tuesday, February 27th, 2024 and will host a conference call beginning at 8:30 A.M. (EST).

The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 888-664-6383, International 617-892-4906, and reference ID # 73063681. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Tuesday, February 27, until midnight Tuesday, March 05, 2024. To listen to the replay, dial 888-390-0541, International 416-764-8677, and use access code 063681#.

About Perrigo 

Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Litigation Securities Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2022.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-release-fourth-quarter-and-fiscal-year-2023-financial-results-on-february-27-2024-302060685.html

SOURCE Perrigo Company plc

Perrigo Company plc (PRGO) plans to issue its financial results on Tuesday, February 27th, 2024.

Interested parties can access the earnings conference call live via webcast on the Perrigo website or by phone.

Yes, a taped replay of the call will be available from February 27 to March 5, 2024.

To listen to the replay, dial 888-390-0541 or International 416-764-8677, and use access code 063681#.
Perrigo Company plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing
Ireland
Dublin

About PRGO

perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).